Study to Assess the Impact on Calcium Levels When Hemodialysis Patients With Secondary Hyperparathyroidism (SHPT) Switch From Cinacalcet to Etelcalcetide

PHASE3CompletedINTERVENTIONAL
Enrollment

158

Participants

Timeline

Start Date

August 12, 2013

Primary Completion Date

January 14, 2014

Study Completion Date

February 14, 2017

Conditions
Hyperparathyroidism, Secondary
Interventions
DRUG

Etelcalcetide

Etelcalcetide is provided as a sterile lyophilized powder to be reconstituted with sterile water for injection.

Trial Locations (40)

11356

Research Site, College Point

19106

Research Site, Philadelphia

22033

Research Site, Fairfax

23666

Research Site, Hampton

29118

Research Site, Orangeburg

30909

Research Site, Augusta

33021

Research Site, Hollywood

33028

Research Site, Pembroke Pines

33071

Research Site, Coral Springs

33150

Research Site, Miami

33156

Research Site, Pinecrest

33614

Research Site, Tampa

39501

Research Site, Gulfport

39705

Research Site, Columbus

46360

Research Site, Michigan City

60805

Research Site, Evergreen Park

63136

Research Site, St Louis

63640

Research Site, Farmington

64111

Research Site, Kansas City

70506

Research Site, Lafayette

70808

Research Site, Baton Rouge

73116

Research Site, Oklahoma City

75402

Research Site, Greenville

76015

Research Site, Arlington

77004

Research Site, Houston

78229

Research Site, San Antonio

78503

Research Site, McAllen

80002

Research Site, Arvada

90022

Research Site, Los Angeles

90262

Research Site, Lynwood

90603

Research Site, Whittier

91702

Research Site, Azusa

91801

Research Site, Alhambra

91910

Research Site, Chula Vista

91942

Research Site, La Mesa

92505

Research Site, Riverside

93308

Research Site, Bakersfield

06473

Research Site, North Haven

03801

Research Site, Portsmouth

07724

Research Site, Eatontown

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Amgen

INDUSTRY

NCT01932970 - Study to Assess the Impact on Calcium Levels When Hemodialysis Patients With Secondary Hyperparathyroidism (SHPT) Switch From Cinacalcet to Etelcalcetide | Biotech Hunter | Biotech Hunter